[HTML] sciencedirect.com

[HTML][HTML] Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour, S Amini… - International Journal of …, 2022 - Elsevier
Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …
被引用次数：34 相关文章
[HTML] nih.gov

[HTML][HTML] Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - ncbi.nlm.nih.gov
Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and
meta-analysis - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - research.rug.nl
INTRODUCTION: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis.

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - europepmc.org
Methods We reviewed the relevant scientific literature published up to January 20, 2022.
The pooled success treatment rate with 95% confidence intervals (CI) was assessed using a …
[PDF] researchgate.net

[PDF][PDF] Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour, S Amini… - researchgate.net
Introduction: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - archive.lstmed.ac.uk
Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - discovery.ucl.ac.uk
Introduction: Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …
[HTML] ijidonline.com

[HTML][HTML] Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - International Journal of …, 2022 - ijidonline.com
Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

MJ Nasiri, M Zangiabadian, E Arabpour… - … Journal of Infectious …, 2022 - archive.lstmed.ac.uk
Introduction Multidrug-resistant tuberculosis (MDR-TB) is a life-threatening condition
needing long poly-chemotherapy regimens. As no systematic reviews/meta-analysis is …